A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agentsSylvia Herter, Marina Bacac|Cancer Immunology Immunotherapy|2016Cited by 137
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trialAndrew D. Zelenetz, Franck Morschhauser, Kylie D. Mason et al.|Blood|2019Cited by 136